Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

CUSIP: 761330109

Q3 2019 13F Holders as of 30 Sep 2019

Holder snapshot 7 signals
Share change
-927,216
Put/Call ratio
166%
SEC-reported price per share
$13.00
Number of holders
106
Value change
-$12,035,697
Number of buys
60
Open additional details 1 more signal available
Number of sells
38
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
104,661,494

Security key

761330109

Report period

Q3 2019

Institutions

106

Top holders

10

Ownership snapshot

Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
30 Jun 2019
13F Lead comparable stake: 5.4% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 5.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 5.4%
ArrowMark Colorado Holdings LLC 4.1%
BlackRock Finance, Inc. 3.4%
FRANKLIN RESOURCES INC 3.4%
Essex Woodlands Management, Inc. 3.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
5.4%
$73,973,000
5,703,467 shares
30 Jun 2019
ArrowMark Colorado Holdings LLC
13F
Company
13F
4.1%
$55,914,000
4,310,996 shares
30 Jun 2019
BlackRock Finance, Inc.
13F
Company
13F
3.4%
$45,759,000
3,528,059 shares
30 Jun 2019
FRANKLIN RESOURCES INC
13F
Company
13F
3.4%
$45,577,000
3,514,050 shares
30 Jun 2019
Essex Woodlands Management, Inc.
13F
Company
13F
3.2%
$43,346,000
3,342,047 shares
30 Jun 2019
JPMORGAN CHASE & CO
13F
Company
13F
2.4%
$31,259,000
2,474,903 shares
30 Jun 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
106
Shares
42,640,327
Rows available
106
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
110
Q3 2019 holders
106
Holder diff
-4
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 value Q3 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .